Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 36INDUSTRY 5OTHER_GOV 2

Study Type

Interventional 2

Sponsor

Conditions

Malignant Female Reproductive System Neoplasm 1Hemorrhage 1Anastomotic Leak 1

Interventions

Cisplatin 50Capecitabine 42apatinib 34Radiotherapy 33Oxaliplatin 33Gemcitabine 33Cyclophosphamide 32Drug Therapy 31Paclitaxel 30Carboplatin 29tislelizumab 27Irinotecan 27Fluorouracil 26Docetaxel 26Bevacizumab 23Surgical Procedures, Operative 21Nivolumab 19pembrolizumab 18fludarabine 18Radiation 16Metformin 16Exercise 16camrelizumab 15S 1 (combination) 14Control Groups 14Blood Specimen Collection 14Pemetrexed 13Standard of Care 12anlotinib 11Neoadjuvant Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Enoxaparin × Clear all
NCT06049758 2023-09-22

D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy

General Committee of Teaching Hospitals and Institutes, Egypt

Phase NA Not yet recruiting
80 enrolled

Hemorrhage, Anastomotic Leak

NCT01356329 2016-05-13

Lovenox

National Guard Health Affairs

Phase 3 Suspended
150 enrolled

Malignant Female Reproductive System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡